MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Characteristics of the interaction between different toxic aggregated species of alpha-synuclein and cell membrane

    A.T. Marvian, D. Morshedi, F. Aliakbari, H. Ghapani, M. Nasuti (Tehran, Islamic Republic of Iran)

    Objective: To determine (1) the interaction rate of each toxic aggregated species of alpha-synuclein (α-Syn) with cell membrane compare to the monomeric form, (2) the…
  • 2016 International Congress

    Differential vulnerability to α-synuclein pathology among neuronal subpopulations

    E. Luna, D.M. Riddle, V.M.Y. Lee, K.C. Luk (Philadelphia, PA, USA)

    Objective: To identify the cell death pathway(s) activated by α-synuclein (α-syn) pathology in an in vitro model of Lewy pathology and determine if neuronal subpopulations…
  • 2016 International Congress

    Circadian dysfunction in Parkinson’s disease: Effects on impaired gait initiation and locomotion

    L. Alibiglou, J. Stewart, G. Bachman, C. Cooper, L. Liu, S. Ancoli-Israel (Chicago, IL, USA)

    Objective: To investigate the impact of circadian rhythm (CR) and time of the day on the magnitude of motor impairments during gait initiation and continuation…
  • 2016 International Congress

    Colonic microbiome in Korean patients with Parkinson’s disease

    D. Lee, Y.N. Kwon, T.B. Ahn (Seoul, Korea)

    Objective: In this study we investigated the relationship between colonic microbiome and clinical features of the patients with homogeneous ethnicity. Background: Colonic microbiome is an…
  • 2016 International Congress

    Molecular landscape of Parkinson’s disease reveals a key role for lipids and lipoproteins

    C.J.H.M. Klemann, G.J.M. Martens, M. Sharma, M.B. Martens, O. Isacson, T. Gasser, J.E. Visser, G. Poelmans (Nijmegen, Netherlands)

    Objective: Integrate available genetic and expression data to generate a molecular landscape of Parkinson's disease (PD) in order to identify key disease mechanisms that may…
  • 2016 International Congress

    DJ-1 regulates intracellular signaling in a highly cell type specific manner

    F. Giesert, D.M. Vogt Weisenhorn, U. Hafen, A. Romanov, A. Kurz-Drexler, W. Wurst (Neuherberg, Germany)

    Objective: To evaluate a cell type specific action of DJ-1, a PD and cancer associated gene, in intracellular signaling pathways. Background: Understanding the pathophysiology of…
  • 2016 International Congress

    Alterations in 14-3-3 protein phosphorylation as a biomarker for neurodegeneration

    T. Yacoubian, X. Chi, G. Cutter, M. McFerrin (Birmingham, AL, USA)

    Objective: To examine whether 14-3-3 phosphorylation is altered in Parkinson's disease and other neurodegenerative disorders. Background: 14-3-3 proteins are a highly conserved family of proteins…
  • 2016 International Congress

    A novel single molecule imaging approach to detect individual protein oligomers in CSF from patients with Parkinson’s disease (PD)

    S. Gandhi, M.H. Horrocks, S.F. Lee, N.W. Wood, D. Klenerman (London, United Kingdom)

    Objective: (1) To develop an ultra-sensitive method to visualize single amyloid oligomers and (2) to compare the oligomer load in CSF from patients with PD…
  • 2016 International Congress

    Cognitive and depressive behavior changes in aged mice with heterozygous deletions of VMAT2 or of DAT

    K. Ma, J. Huang, L. Liu, H. Jiang, X. Xu, C. Han, Y. Shen, Y. Xia, S. Guo, L. Wang, N. Xiong, T. Wang (Wuhan, People's Republic of China)

    Objective: To evaluate cognitive and depressive behavior in aged mice with heterozygous deletions of vesicular monoamine transporter (VMAT2) or of Dopamine transporter (DAT). Background: VMAT2…
  • 2016 International Congress

    Detailed proteomic analysis of early PD brain highlights altered expression of mitochondrial proteins as an important event in sporadic PD

    S. Gandhi, C.E. Murray, W.E. Heywood, J.L. Holton, K. Mills, T. Revesz (London, United Kingdom)

    Objective: To uncover early pathogenic events occurring prior to neuronal loss and Lewy body formation in human PD brain. Background: In PD, pathological changes spread…
  • « Previous Page
  • 1
  • …
  • 1816
  • 1817
  • 1818
  • 1819
  • 1820
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley